Dna (recombinant Adeno-associated Virus 2 Vector Lys-saf302 Human N-sulfoglucosamine Sulfohydrolase Cdna-specifying) Uses, Dosage, Side Effects and more
Dna (recombinant Adeno-associated Virus 2 Vector Lys-saf302 Human N-sulfoglucosamine Sulfohydrolase Cdna-specifying) is under investigation in clinical trial NCT03612869 (Study of aavrh10-h.sgsh Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)).
Attribute | Details |
---|---|
Trade Name | Dna (recombinant Adeno-associated Virus 2 Vector Lys-saf302 Human N-sulfoglucosamine Sulfohydrolase Cdna-specifying) |
Generic | Olenasufligene relduparvovec |
Olenasufligene relduparvovec Other Names | Aavrh10-hsgsh, Dna (recombinant adeno-associated virus 2 vector lys-saf302 human n-sulfoglucosamine sulfohydrolase cdna-specifying), Olenasufligene relduparvovec |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |